Camillo Aliberti
- Hepatology top 1%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Surgery top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Giammaria FiorentiniGiorgio BeneaMassimo TilliFrancesca MontagnaniLuca MulazzaniGina TurrisiAndrea MambriniPaolo Coschiera
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (33 papers)Colorectal Cancer Treatments and Studies (15 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Camillo Aliberti
67 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 80
- Hepatology 868
- Oncology 786
- Pulmonary and Respiratory Medicine 535
- Surgery 528
- Radiology, Nuclear Medicine and Imaging 195
Countries citing papers authored by Camillo Aliberti
This map shows the geographic impact of Camillo Aliberti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camillo Aliberti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camillo Aliberti more than expected).
Fields of papers citing papers by Camillo Aliberti
This network shows the impact of papers produced by Camillo Aliberti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camillo Aliberti. The network helps show where Camillo Aliberti may publish in the future.
Co-authorship network of co-authors of Camillo Aliberti
This figure shows the co-authorship network connecting the top 25 collaborators of Camillo Aliberti. A scholar is included among the top collaborators of Camillo Aliberti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camillo Aliberti. Camillo Aliberti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 10 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 18 | |
| 6 | 29 | |
| 7 | 4 | |
| 8 | 12 | |
| 9 | 4 | |
| 10 | 8 | |
| 11 | 43 | |
| 12 | 2 | |
| 13 | 2 | |
| 14 | 1 | |
| 15 | 10 | |
| 16 | 1 | |
| 17 | 18 | |
| 18 | 11 | |
| 19 | 20 | |
| 20 | 96 |
About Camillo Aliberti
Camillo Aliberti is a scholar working on Hepatology, Oncology and Ophthalmology, having authored 71 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (33 papers), Colorectal Cancer Treatments and Studies (15 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers). The work is most often cited by research in Hepatology (868 citations), Oncology (786 citations) and Pulmonary and Respiratory Medicine (535 citations). Camillo Aliberti has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Giammaria Fiorentini, Giorgio Benea, Massimo Tilli, Francesca Montagnani, Luca Mulazzani, Gina Turrisi, Andrea Mambrini, Paolo Coschiera, Vincenzo Catalano and Donatella Sarti. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.